e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Smoking cessation in respiratory diseases: methods and results
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nasal and bronchial inflammation markers in smokers before and after smoking cessation program
M. Sanchez, A. Ramirez, R. H. Sansores, R. Herandez, J. L. Banales (Mexico City, Mexico)
Source:
Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Session:
Smoking cessation in respiratory diseases: methods and results
Session type:
Oral Presentation
Number:
1687
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sanchez, A. Ramirez, R. H. Sansores, R. Herandez, J. L. Banales (Mexico City, Mexico). Nasal and bronchial inflammation markers in smokers before and after smoking cessation program. Eur Respir J 2005; 26: Suppl. 49, 1687
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005
Airway hyperresponsiveness and its correction during the smoking cessation program
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
Source: Eur Respir J 2004; 23: 464-476
Year: 2004
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers
Source: Eur Respir J 2013; 41: 1058-1067
Year: 2013
Duration of smoking cessation and bronchial inflammation in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004
Smoking cessation attenuates AMP but not methacholine airway hyperresponsiveness in heavy smokers
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006
Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD
Source: Eur Respir J 2004; 24: 391-396
Year: 2004
Effects of one year smoking cessation on inflammation in induced sputum of smokers with and without COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
An increase in bronchial responsiveness is associated with continuing or restarting smoking
Source: Annual Congress 2005 - Highlights of asthma epidemiology
Year: 2005
Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation
Source: Eur Respir J 2005; 25: 447-454
Year: 2005
Morphological markers of resistance bronchial mucosa of smokers to the development of COPD
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
CD8+ve airway inflammation in COPD: The impact of smoking status
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003
Surrogate markers of airway inflammation are not increased in actively smoking mild to moderate asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 283s
Year: 2001
Acute effect of passive cigarette smoking on airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 129s
Year: 2005
Determinants of airway responsiveness to histamine in children
Source: Eur Respir J 2005; 25: 462-467
Year: 2005
COPD disease progression and airway inflammation: uncoupled by smoking cessation
Source: Eur Respir J 2005; 26: 764-766
Year: 2005
Influence of smoking on airway function and inflammation of asthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 283s
Year: 2004
Prevalence of airflow obstruction in smokers and never-smokers in Switzerland
Source: Eur Respir J 2010; 36: 1259-1269
Year: 2010
The value of behavioral regulation in patients with bronchial asthma in case of smoking cessation
Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept